Dystrophin is a large cytoskeletal protein critical for muscle fiber stability and function. While primarily studied in the context of Duchenne (DMD) and Becker (BMD) muscular dystrophies, increasing evidence indicates that dystrophin and its brain isoforms play important roles in neuronal function and cognitive processes. This page provides comprehensive information about dystrophin's structure, function, and relevance to neurodegenerative diseases.
Dystrophin is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
Dystrophin is a large cytoskeletal protein (427 kDa) critical for muscle fiber stability and function. Mutations cause Duchenne and Becker muscular dystrophies[1]. Beyond muscle, dystrophin is expressed in the brain, where its isoforms play critical roles in cognitive function[2].
Dystrophin contains several distinct structural domains[3]:
Dystrophin is expressed from multiple promoters producing tissue-specific isoforms[4]:
Dystrophin serves as a scaffold for multiple signaling proteins[5]:
In the central nervous system, dystrophin plays critical roles in[6][7]:
Duchenne muscular dystrophy is caused by frameshift, nonsense, or large deletions resulting in[8]:
Becker muscular dystrophy results from in-frame deletions that[9]:
Mutations affecting brain dystrophin isoforms (Dp140, Dp71) are associated with[10][11]:
While dystrophin is not directly implicated in AD pathogenesis, several connections exist[12][13]:
Understanding dystrophin's role in synaptic function may inform therapeutic strategies for:
Hoffman EP, Brown RH Jr, Kunkel LM. Dystrophin: the protein product of the Duchenne muscular dystrophy locus. Cell. 1987. ↩︎
Monaco AP, Neve RL, Colletti-Feener C, Bertelson CJ, Kurnit DM, Kunkel LM. Isolation of candidate cDNA clones for the Duchenne muscular dystrophy locus. Nature. 1986. ↩︎
Koenig M, Monaco AP, Kunkel LM. The complete sequence of dystrophin predicts a rod-shaped cytoskeletal protein. Cell. 1988. ↩︎
Muntoni F, Torelli S, Ferlini A. Dystrophin and mutations: one gene, several phenotypes. Lancet Neurol. 2003. ↩︎
Brenman JE, Chao DS, Xia H, Aldape K, Bredt DS. Nitric oxide synthase complexed with dystrophin and absent from skeletal muscle sarcolemma in Duchenne muscular dystrophy. Cell. 1995. ↩︎
Blake DJ, Weir A, Newey SE, Davies KE. Function and genetics of dystrophin and dystrophin-associated proteins in muscle. Physiol Rev. 2002. ↩︎
Simon MJ, Luo M, Morshead CM. A transcriptome-based assessment of the astrocytic dystrophin-associated complex in the developing human brain. J Neurosci Res. 2018. ↩︎
Emery AE, Muntoni F, Quinlivan R. Duchenne Muscular Dystrophy. Duchenne Muscular Dystrophy. 2015. ↩︎
Becker PE, Kiener F. [A new X-chromosomal muscular dystrophy (Becker type)]. Arch Psychiatr Nervenkr Z Gesamte Neurol Psychiatr. 1955. ↩︎
Daoud F, Candelario-Martínez A, Billard JM, et al. Role of brain dystrophin isoforms in cognitive function: from mice to humans. J Neurosci Res. 2009. ↩︎
Anderson JL, Head SI, Morley JW. Dystrophin and muscle pathology. Handb Clin Neurol. 2024. ↩︎
Yamaguchi Y, Miyawaki Y, Tsukaguchi T, et al. Vascular amyloid alters astrocytic water and potassium channels in mouse models and humans with Alzheimer's disease. Neurosci Lett. 2009. ↩︎
Ruggieri M, McShane R, D'Amico A, et al. Dystrophin and the blood-brain barrier. J Cereb Blood Flow Metab. 2023. ↩︎
Ruggieri M, Scuderi C, McShane MR, et al. The expression of the distal dystrophin isoforms Dp140 and Dp71 in the human epileptic hippocampus in relation to cognitive functioning. Epilepsia Open. 2018. ↩︎